Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

MRNX

Defiance Daily Target 2X Long MRNA ETF

28.31

Aug 10 • 3:59 PM ET +0.39 (1.38%)

28.04

Aftermarket • 7:39 PM ET -0.27 (-0.95%)

Financial Exchange Traded Fund USA NYSE

Category	Equity - Leveraged / Inverse
Sponsor	Defiance ETFs
Fund Family
Index	-
Index Weighting
Active/Passive
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Expense	1.31%
Inverse/Leveraged
IPO	Feb 04, 2026

Asset Type	Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short	No / Yes

Tags	U.S.
Tags	single-asset
Tags	MRNA
Tags	leverage
Tags	-
Tags	-
Tags	-
Sector/Theme
Region
SMA20	1.25%
SMA50	-9.05%
SMA200	2.08%

Return% 1Y	-
Return% 3Y	-
Return% 5Y	-
Return% 10Y
Return% SI
Flows% 1M	51.93%
Flows% 3M	229.99%
Flows% YTD	166.10%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades

Total Holdings	8
AUM	4.45M
NAV/sh
52W High	62.80 -54.92%
52W Low	14.95 89.37%
Volatility	12.40% 10.26%
ATR (14)	3.73
RSI (14)	48.17
Beta	-
Rel Volume	0.77
Avg Volume	37.40K
Volume	28,797

Perf Week	15.14%
Perf Month	-27.39%
Perf Quarter	-0.18%
Perf Half Y	51.08%
Perf YTD	37.36%
Perf Year	-
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Prev Close	27.92
Price	28.31
Change %	1.38%

Feb-09-26 04:08PM

Betting On Moderna? This New Defiance ETF Turns The Volume Up 2X

(Benzinga)

Defiance Daily Target 2X Long MRNA ETF is an actively managed, single-stock leveraged exchange-traded fund designed to provide 200% of the daily share price performance of Moderna, Inc. (MRNA). The fund is intended for sophisticated investors and active traders who seek to express tactical bullish views on mRNA-based biotechnology innovation through amplified daily exposure.

open in yahoo | open in marketwatch | open in google

MRNX

Defiance Daily Target 2X Long MRNA ETF

Upgrade your Finviz experience